FR940204-2-00088 FR940204-2-00063 Health Resources and Services Administration Advisory Council; Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), announcement is made of the following National Advisory bodies scheduled to meet during the months of February and March 1994: Name: National Advisory Council on Migrant Health. Date and Time: February 25&hyph;26, 1994_9 a.m. Place: Holiday Inn_Governors House, Rhode Island Avenue & 17th Street, NW., Washington, DC 20036. The meeting is open to the public. Purpose: The Council is charged with advising, consulting with, and making recommendations to the Secretary and the Administrator, Health Resources and Services Administration, concerning the organization, operation, selection, and funding of Migrant Health Centers and other entities under grants and contracts under section 329 of the Public Health Service Act. Agenda: The agenda includes a overview of Council general business activities and priorities; discussion of 1994 National Advisory Council on Migrant Health Recommendations with Federal representatives and subcommittee meetings. Anyone requiring information regarding the subject Council should contact Helen Kavanagh, Migrant Health Program, Staff Support to the National Advisory Council on Migrant Health, Bureau of Primary Care, Health Resources and Services Administration, 4350 East West Highway, Room 7A6&hyph;1, Rockville, Maryland 20857, Telephone (301) 594&hyph;430. * * * * * Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 2, 1994; 9 a.m.&hyph;5 p.m., March 3, 1994; 8:30 a.m.&hyph;5 p.m. Place: Parklawn Building, Conference Rooms G & H, 5600 Fishers Lane, Rockville, Maryland 20857. The meeting is open to the public. Purpose: The Commission: (1) Advises the Secretary on the implementation of the Program, (2) on its own initiative or as the result of the filing of a petition, recommends changes in the Vaccine Injury Table, (3) advises the Secretary in implementing the Secretary's responsibilities under section 2127 regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions, (4) surveys Federal, State, and local programs and activities relating to the gathering of information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b), and advises the Secretary on means to obtain, compile, publish, and use credible data related to the frequency and severity of adverse reactions associated with childhood vaccines, and (5) recommends to the Director of the National Vaccine Program research related to vaccine injuries which should be conducted to carry out the National Vaccine Injury Compensation Program. Agenda: The full Commission will meet commencing at 9 a.m. on Wednesday, March 2 until 2:45 p.m., and from 8:30 a.m. to 5 p.m. on Thursday, March 3. Agenda items will include, but not be limited to, a presentation on the Food and Drug Administration's procedures for reviewing data and applications for the approval and licensure of new vaccines; a report of the Institute of Medicine (IOM) recent British Medical Journal article and its implications for the IOM's Section 312 Report; discussion of recent meetings and activities to revise the Vaccine Information Materials; routine Program reports; reports from the National Vaccine Program, and reports from the ACCV Subcommittees. In addition, on March 2, following the meeting of the full Commission, there will be simultaneous meetings of two of the Commission's Working Subcommittees: * * * * * Name: Financial Review Subcommittee of the Advisory Commission on Childhood Vaccines. Time: March 2, 1994, 3 p.m.&hyph;5 p.m. Place: Conference Room H, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Open for entire meeting.
